Actively Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Led by Intra-Cellular Therapies, Inc. · Updated on 2026-01-13
370
Participants Needed
65
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the treatment of psychosis in patients with AD.
CONDITIONS
Official Title
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to understand the trial and provide signed informed consent or have a legally authorized representative provide consent
- Meets clinical criteria for Alzheimer's disease based on 2011 NIA-AA guidelines confirmed by blood biomarker, cerebrospinal fluid biomarker, or amyloid PET brain scan
- Meets criteria for psychosis according to the International Psychogeriatric Association at screening and baseline
- Scores 2 or higher on any item of the BEHAVE-AD psychosis subscale at screening and baseline
- Has a Clinical Global Impression-Severity (CGI-S) score of 4 or higher at screening and baseline
- Has Mini-Mental State Examination 2nd Edition Standard Version (MMSE-2:SV) score between 6 and 24 at screening with sufficient verbal ability
- Has a designated caregiver (relative, housemate, close friend, or professional caregiver)
You will not qualify if you...
- Psychotic symptoms primarily due to delirium, substance abuse, or other medical conditions like hypothyroidism
- Diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, or other non-Alzheimer's psychotic disorders
- At risk of suicidal behavior, considered an imminent danger to self or others, or has attempted suicide within 2 years prior to screening
- Unable or unwilling to stop other psychotropic or CNS-effect medications as reviewed by the study sponsor
- Hospitalized or receiving skilled nursing care for medical conditions other than dementia
- Bedridden or has unstable medical conditions that increase risk or interfere with study evaluations
- In hospice or end-of-life care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 65 locations
1
Clinical Site
Anaheim, California, United States, 92805
Actively Recruiting
2
Clinical Site
Costa Mesa, California, United States, 92626
Active, Not Recruiting
3
Clinical Site
Lafayette, California, United States, 94549
Not Yet Recruiting
4
Clinical Site
Los Alamitos, California, United States, 90720
Withdrawn
5
Clinical Site
Newport Beach, California, United States, 92660
Actively Recruiting
6
Clinical Site
Orange, California, United States, 92866
Actively Recruiting
7
Clinical Site
Bonita Springs, Florida, United States, 34134
Actively Recruiting
8
Clinical Site
Brandon, Florida, United States, 33511
Actively Recruiting
9
Clinical Site
Coral Springs, Florida, United States, 33067
Actively Recruiting
10
Clinical Site
Delray Beach, Florida, United States, 33445
Actively Recruiting
11
Clinical Site
Doral, Florida, United States, 33178
Actively Recruiting
12
Clinical Site
Homestead, Florida, United States, 33033
Actively Recruiting
13
Clinical Site
Maitland, Florida, United States, 32751
Actively Recruiting
14
Clinical Site
Miami, Florida, United States, 33135
Actively Recruiting
15
Clinical Site
Miami, Florida, United States, 33144
Actively Recruiting
16
Clinical Site
Miami, Florida, United States, 33155
Actively Recruiting
17
Clinical Site
Miami, Florida, United States, 33166
Actively Recruiting
18
Clinical Site
Miami, Florida, United States, 33186
Actively Recruiting
19
Clinical Site
Orlando, Florida, United States, 32803
Actively Recruiting
20
Clinical Site
Sarasota, Florida, United States, 34239
Actively Recruiting
21
Clinical Site
Tampa, Florida, United States, 33613
Actively Recruiting
22
Clinical Site
Tampa, Florida, United States, 33614
Actively Recruiting
23
Clinical Site
Toms River, New Jersey, United States, 08755
Actively Recruiting
24
Clinical Site
Charlotte, North Carolina, United States, 28211
Actively Recruiting
25
Clinical Site
Cypress, Texas, United States, 77429
Actively Recruiting
26
Clinical Site
San Antonio, Texas, United States, 78229
Actively Recruiting
27
Clinical Site
Bellevue, Washington, United States, 98007
Actively Recruiting
28
Clinical Site
Blagoevgrad, Bulgaria, 2700
Actively Recruiting
29
Clinical Site
Cherven Bryag, Bulgaria, 5980
Actively Recruiting
30
Clinical Site
Sofia, Bulgaria, 1377
Actively Recruiting
31
Clinical Site
Sofia, Bulgaria, 1408
Actively Recruiting
32
Clinical Site
Sofia, Bulgaria, 1510
Actively Recruiting
33
Clinical Site
Sofia, Bulgaria, 1680
Actively Recruiting
34
Clinical Site
Stara Zagora, Bulgaria, 6000
Actively Recruiting
35
Clinical Site
Vratsa, Bulgaria, 3000
Actively Recruiting
36
Clinical Site_2
Zagreb, Croatia, 10000
Actively Recruiting
37
Clinical Site
Zagreb, Croatia, 10000
Actively Recruiting
38
Clinical Site
Zagreb, Croatia, 10090
Actively Recruiting
39
Clinical Site
Brno, Czechia, 60200
Actively Recruiting
40
Clinical Site
Brno, Czechia, 62800
Actively Recruiting
41
Clinical Site
Hradec Králové, Czechia, 50002
Actively Recruiting
42
Clinical Site
Prague, Czechia, 18600
Actively Recruiting
43
Clinical Site
Bydgoszcz, Poland, 85-080
Actively Recruiting
44
Clinical Site
Ścinawa, Poland, 59-330
Actively Recruiting
45
Clinical Site
Bucharest, Romania, 10825
Actively Recruiting
46
Clinical Site
Bucharest, Romania, 40874
Actively Recruiting
47
Clinical Site
Bucharest, Romania, 41914
Actively Recruiting
48
Clinical Site
Bucharest, Romania, 60222
Actively Recruiting
49
Clinical Site
Galati, Romania, 800179
Actively Recruiting
50
Clinical Site
Sibiu, Romania, 550281
Actively Recruiting
51
Clinical Site
Belgrade, Serbia, 11000
Actively Recruiting
52
Clinical Site
Kovin, Serbia, 26220
Actively Recruiting
53
Clinical Site
Kragujevac, Serbia, 34000
Actively Recruiting
54
Clinical Site
Niš, Serbia, 18000
Actively Recruiting
55
Clinical Site
Novi Kneževac, Serbia, 23330
Actively Recruiting
56
Clinical Site
Banská Bystrica, Slovakia, 97404
Actively Recruiting
57
Clinical Site
Bratislava, Slovakia, 81369
Actively Recruiting
58
Clinical Site
Košice, Slovakia, 4001
Actively Recruiting
59
Clinical Site
Košice, Slovakia, 4190
Actively Recruiting
60
Clinical Site
Krompachy, Slovakia, 5342
Actively Recruiting
61
Clinical Site
Vranov nad Topľou, Slovakia, 9301
Actively Recruiting
62
Clinical Site
Albacete, Spain, 2006
Actively Recruiting
63
Clinical Site
Madrid, Spain, 28046
Not Yet Recruiting
64
Clinical Site
Zamora, Spain, 49021
Not Yet Recruiting
65
Clinical Site
Zaragoza, Spain, 50012
Actively Recruiting
Research Team
I
ITI Clinical Trials
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here